Tecan Execs to Discuss Strategy at Morgan Stanley Healthcare Conference
Event summary
- Tecan Group AG will participate in the 24th Annual Morgan Stanley Healthcare Conference on September 14, 2026.
- CEO Monica Manotas will lead a fireside chat with Morgan Stanley analysts, joined by CFO Camila Japur and SVP Martin Brändle.
- The event will be webcast live and available for replay for 120 days.
- Tecan reported CHF 883 million in sales for 2025.
The big picture
Tecan's participation in the Morgan Stanley Healthcare Conference underscores its focus on engaging with institutional investors amid a shifting landscape in lab automation. The company's OEM business model positions it as a key enabler of healthcare innovation, but it must navigate increasing competition from both specialized and diversified players. With CHF 883 million in 2025 revenue, Tecan's strategic updates will be closely watched by investors assessing its ability to scale globally.
What we're watching
- Strategic Messaging
- How Tecan frames its growth narrative amid rising competition in laboratory automation.
- Financial Guidance
- Whether Tecan provides updated revenue or margin expectations during the fireside chat.
- Market Positioning
- The pace at which Tecan expands its OEM partnerships in high-growth healthcare segments.
Related topics